Journals / Bozok Tıp Dergisi / 2017 / Cilt: 7 Sayı: 3

GESTASYONEL DİYABETLİ GEBELERDE FETAL VE MATERNAL APELİN DÜZEYLERİ Maternal and Fetal Apelin Levels in Gestational Diabetes Mellitus

Pages
58–66
Publication Date
2017-09-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

GESTASYONEL DİYABETLİ GEBELERDE FETAL VE MATERNAL APELİN DÜZEYLERİ Maternal and Fetal Apelin Levels in Gestational Diabetes Mellitus

📌 3 Key Takeaways

🎯
Objective & Hypothesis:GESTASYONEL DİYABETLİ GEBELERDE FETAL VE MATERNAL APELİN DÜZEYLERİ Maternal and Fetal Apelin Levels in Gestational Diabetes Mellitus
📊
Key Findings & Data:GESTASYONEL DİYABETLİ GEBELERDE FETAL VE MATERNAL APELİN DÜZEYLERİ Maternal and Fetal Apelin Levels in Gestational Diabetes Mellitus
💡
Conclusion & Impact:GESTASYONEL DİYABETLİ GEBELERDE FETAL VE MATERNAL APELİN DÜZEYLERİ Maternal and Fetal Apelin Levels in Gestational Diabetes Mellitus
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:GESTASYONEL DİYABETLİ GEBELERDE FETAL VE MATERNAL APELİN DÜZEYLERİ Maternal and Fetal Apelin Levels in Gestational Diabetes Mellitus

Özet

GESTASYONEL DİYABETLİ GEBELERDE FETAL VE MATERNAL APELİN DÜZEYLERİ Maternal and Fetal Apelin Levels in Gestational Diabetes Mellitus

🔖

Cite This Article

Cündübey, C. R., Tayyar, A. (2017). GESTASYONEL DİYABETLİ GEBELERDE FETAL VE MATERNAL APELİN DÜZEYLERİ Maternal and Fetal Apelin Levels in Gestational Diabetes Mellitus. Bozok Tıp Dergisi, Cilt: 7 Sayı: 3, 58–66. https://ajindex.com/articles/925791

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Clark CM Jr, Qiu C, Amerman B, Porter B, Fineberg N, Aldasouqi S. Gestational diabetes: should it be added to the syndrome of insulin resistance? Diabetes Care. 1997;20(5):867-71. 7. Masri B, Morin N, Pedebernade L, Knibiehler B, Audigier Y. The apelin receptor is coupled to Gi1 or Gi2 protein and is differentially desensitized by apelin fragments. Journal of Biological Chemistry. 2006;281(27):18317-26. 8. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX,. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor Biochemical and Biophysical Research Communications 1998;251(2):471-6. 9. Boucher J, Masri B, Daviaud D, Gesta S, Guigné C, Mazzucotelli A. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology. 2005;146(4):1764-71. 10. Li L, Yang G, Li Q, Tang Y, Yang M, Yang H. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Experimental and Clinical Endocrinology & Diabetes. 2006;114(10):544-8. 11. Boucher J, Masri B, Daviaud D, Gesta S, Guigné C, Mazzucotelli A. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology. 2005;146(4):1764-71. 12. Soriguer F, Garrido-Sanchez L, Garcia-Serrano S, Garcia-Almeida JM, Garcia-Arnes J, Tinahones FJ. Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Obesity Surgery. 2009;19(11):1574-80. 13. Habata Y, Fujii R, Hosoya M, Fukusumi S, Kawamata Y, Hinuma S, et al. Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. Biochimical Biophysica Acta 1999;1452(1):25-35. 14. Medhurst AD, Jennings CA, Robbins MJ, Davis RP, Ellis C, Winborn KY, et al. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. Journal of Neurochemistry 2003;84(5):1162-72.
  2. Clark CM Jr, Qiu C, Amerman B, Porter B, Fineberg N, Aldasouqi S. Gestational diabetes: should it be added to the syndrome of insulin resistance? Diabetes Care. 1997;20(5):867-71. 7. Masri B, Morin N, Pedebernade L, Knibiehler B, Audigier Y. The apelin receptor is coupled to Gi1 or Gi2 protein and is differentially desensitized by apelin fragments. Journal of Biological Chemistry. 2006;281(27):18317-26. 8. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX,. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor Biochemical and Biophysical Research Communications 1998;251(2):471-6. 9. Boucher J, Masri B, Daviaud D, Gesta S, Guigné C, Mazzucotelli A. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology. 2005;146(4):1764-71. 10. Li L, Yang G, Li Q, Tang Y, Yang M, Yang H. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Experimental and Clinical Endocrinology & Diabetes. 2006;114(10):544-8. 11. Boucher J, Masri B, Daviaud D, Gesta S, Guigné C, Mazzucotelli A. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology. 2005;146(4):1764-71. 12. Soriguer F, Garrido-Sanchez L, Garcia-Serrano S, Garcia-Almeida JM, Garcia-Arnes J, Tinahones FJ. Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Obesity Surgery. 2009;19(11):1574-80. 13. Habata Y, Fujii R, Hosoya M, Fukusumi S, Kawamata Y, Hinuma S, et al. Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. Biochimical Biophysica Acta 1999;1452(1):25-35. 14. Medhurst AD, Jennings CA, Robbins MJ, Davis RP, Ellis C, Winborn KY, et al. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. Journal of Neurochemistry 2003;84(5):1162-72.